Trial Profile
The prospective, open-lable, single-arm, single-center phase II clinical study of endostar combined with AI in first-line treating patients with recurrent/metastatic soft tissue sarcoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Alveolar soft part sarcoma; Clear cell sarcoma; Leiomyosarcoma; Soft tissue sarcoma; Synovial sarcoma
- Focus Therapeutic Use
- 09 May 2017 New trial record